Defence Therapeutics Inc. (DTC.CN)
CAD 0.52
(0.0%)
CAD 0.52
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.65 Million CAD | 95.29% |
| 2022 | 6.48 Million CAD | -11.47% |
| 2021 | 7.32 Million CAD | 156.02% |
| 2020 | 2.85 Million CAD | 324.74% |
| 2019 | 673.18 Thousand CAD | 1504.88% |
| 2018 | 41.94 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 8.3 Million CAD | 292.57% |
| 2023 Q4 | 1.18 Million CAD | 0.09% |
| 2023 Q1 | 2.11 Million CAD | 22.51% |
| 2023 Q3 | 1.18 Million CAD | -85.69% |
| 2022 Q1 | 1.66 Million CAD | -23.41% |
| 2022 Q2 | 1.91 Million CAD | 15.01% |
| 2022 FY | 6.53 Million CAD | -10.77% |
| 2022 Q4 | 1.72 Million CAD | 38.98% |
| 2022 Q3 | 1.24 Million CAD | -35.08% |
| 2021 Q1 | 1.52 Million CAD | -9.19% |
| 2021 FY | 7.32 Million CAD | 156.02% |
| 2021 Q4 | 2.17 Million CAD | 29.49% |
| 2021 Q3 | 1.67 Million CAD | -13.59% |
| 2021 Q2 | 1.94 Million CAD | 26.87% |
| 2020 Q2 | 442.25 Thousand CAD | 965.55% |
| 2020 Q1 | 41.5 Thousand CAD | -91.2% |
| 2020 FY | 2.85 Million CAD | 324.74% |
| 2020 Q4 | 1.68 Million CAD | 143.9% |
| 2020 Q3 | 690.74 Thousand CAD | 56.19% |
| 2019 Q3 | 192.27 Thousand CAD | 6601.64% |
| 2019 Q2 | 2869.00 CAD | -56.1% |
| 2019 Q1 | 6536.00 CAD | 0.0% |
| 2019 Q4 | 471.5 Thousand CAD | 145.23% |
| 2019 FY | 673.18 Thousand CAD | 1504.88% |
| 2018 FY | 41.94 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | -143.775% |
| Asep Medical Holdings Inc | 7.74 Million CAD | -63.461% |
| BetterLife Pharma Inc. | 3.24 Million CAD | -290.582% |
| BioVaxys Technology Corp. | 2.4 Million CAD | -426.754% |
| ChitogenX Inc. | 2.83 Million CAD | -347.201% |
| Rapid Dose Therapeutics Corp. | 4.2 Million CAD | -200.723% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | -2142.684% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | -148.842% |
| Glow Lifetech Corp. | 25.71 Thousand CAD | -49115.641% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | -1775.717% |
| Pharmala Biotech Holdings Inc. | 1.21 Million CAD | -939.876% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | -17456.289% |
| MYND Life Sciences Inc. | 1.47 Million CAD | -758.144% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | -952.633% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | -315.751% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | -1214.037% |
| Telescope Innovations Corp. | 6.35 Million CAD | -99.232% |